| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.13.6.791 |
| P698 | PubMed publication ID | 8388713 |
| P50 | author | John Keaney | Q70457038 |
| P2093 | author name string | J Loscalzo | |
| S A Francis | |||
| J S Stamler | |||
| J A Osborne | |||
| D I Simon | |||
| O Jaraki | |||
| D J Singel | |||
| P433 | issue | 6 | |
| P304 | page(s) | 791-799 | |
| P577 | publication date | 1993-06-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor | |
| P478 | volume | 13 |
| Q41835276 | A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations |
| Q46050405 | A redox site involved in integrin activation |
| Q40730346 | Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo |
| Q40160831 | Acute supplementation of N-acetylcysteine does not affect muscle blood flow and oxygenation characteristics during handgrip exercise. |
| Q74828390 | Aspirin inhibits granulocyte and monocyte adherence to saphenous vein endothelia in a process not mediated by nitric oxide |
| Q40418236 | Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action |
| Q92355916 | Attenuation of Thrombin-Mediated Fibrin Formation via Changes in Fibrinogen Conformation Induced by Reaction with S-nitroso-N-acetylpenicillamine, but not S-nitrosoglutathione |
| Q43070990 | Autoimmunovascular regulation: morphine and anandamide and ancondamide stimulated nitric oxide release |
| Q33876371 | Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor. |
| Q41485243 | Clinical chemistry and molecular biology of homocysteine metabolism: an update |
| Q41807795 | Copper chelation-induced reduction of the biological activity of S-nitrosothiols |
| Q41661664 | Diabetes-induced alterations in platelet metabolism |
| Q46024028 | Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. |
| Q35027134 | Effect of L-buthionine-(S,R)-sulphoximine, an inhibitor of gamma-glutamylcysteine synthetase on peroxynitrite- and endotoxic shock-induced vascular failure |
| Q41120249 | Effects of nitric oxide on cholesterol metabolism in macrophages |
| Q41635553 | Endothelial dysfunction and atherothrombotic occlusive disease. |
| Q59136926 | Erythrocytic bioactivation of nitrite and its potentiation by far-red light |
| Q34034199 | Evidence for S-nitrosothiol-dependent changes in fibrinogen that do not involve transnitrosation or thiolation. |
| Q38203516 | Exhaled nitric oxide as a biomarker in COPD and related comorbidities |
| Q78106230 | Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability |
| Q33746622 | Homocysteine: cholesterol of the 90s? |
| Q34249956 | Impaired homocysteine metabolism and atherothrombotic disease |
| Q43737734 | Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia |
| Q51722366 | Influence of exercise intensity on respiratory muscle fatigue and brachial artery blood flow during cycling exercise. |
| Q73048662 | Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial |
| Q41628605 | Inhaled nitric oxide in the premature infant: animal models and clinical experience |
| Q35042989 | Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy |
| Q43797327 | Lack of correlation between the observed stability and pharmacological properties of S-nitroso derivatives of glutathione and cysteine-related peptides |
| Q35824683 | N-acetylcysteine inhibits muscle fatigue in humans |
| Q34291742 | Nitric oxide and the liver |
| Q41005261 | Nitric oxide: delivery, measurement, and clinical application |
| Q33610044 | Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules |
| Q73604837 | Physiology and biochemistry of endothelial function in children with chronic renal failure |
| Q33376028 | Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studies. |
| Q39419192 | Platelets redox balance assessment: Current evidence and methodological considerations. |
| Q37603375 | Polynitrosylated proteins: characterization, bioactivity, and functional consequences. |
| Q40541975 | Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn |
| Q34222592 | Redox Pioneer: Professor Joseph Loscalzo |
| Q90363169 | Regulation of the Proteolytic Activity of Cysteine Cathepsins by Oxidants |
| Q42136391 | Role of a copper (I)-dependent enzyme in the anti-platelet action of S-nitrosoglutathione |
| Q27011922 | Role of colloids in traumatic brain injury: Use or not to be used? |
| Q24532818 | Role of ergothioneine on S-nitrosoglutathione catabolism |
| Q37967558 | Routes for formation of S-nitrosothiols in blood |
| Q40460088 | S-Nitrosothiols and the Bioregulatory Actions of Nitrogen Oxides Through Reactions with Thiol Groups |
| Q34391779 | S-nitrosoglutathione acts as a small molecule modulator of human fibrin clot architecture |
| Q37710137 | S-nitrosothiols as selective antithrombotic agents - possible mechanisms |
| Q39926921 | S-nitrosylated human serum albumin-mediated cytoprotective activity is enhanced by fatty acid binding |
| Q33688733 | The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals |
| Q42448372 | The effect of hypercholesterolemia on platelet soluble guanylyl cyclase |
| Q39342123 | The role of inorganic nitrate and nitrite in CVD. |
Search more.